
Humalog Cartridge100 unit/m
Healthcare Pharmaceuticals Ltd.
Insulin Lispro is a rapid-acting human insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus.
Insulin Lispro is a rapid-acting human insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus.
Insulin Lispro is not a substitute for individualized dose titration; the exact dose and timing must always be determined by a treating physician based on each patient's blood glucose monitoring, meal pattern, and activity level.
The dose of Insulin Lispro is not fixed and must be individualized by a physician for each patient based on blood glucose monitoring, metabolic needs, meal content, and activity level. It is intended for mealtime (bolus) coverage and is usually given together with a longer-acting basal insulin as part of a complete regimen.
Because of its rapid onset, Insulin Lispro should generally be injected within 15 minutes before a meal or immediately after starting a meal, as directed by the prescriber.
Dose requirements may need adjustment with changes in physical activity, meals, concurrent illness, renal or hepatic impairment, or other medications (see Interactions). Do not adjust the dose without medical advice.
Insulin Lispro is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.